Tela Bio names clinical development VP

Soft-tissue reconstruction company Tela Bio (NSDQ:TELA) announced the appointment of Dr. Bruce Freedman as VP of clinical development.

Freedman has practiced 32 years as a general surgeon specializing in hernia repair and abdominal wall reconstruction. He joined Tela Bio after having used its OviTex material in his practice.

The Malvern, Penn.-based company’s tech platform is based on polymer interwoven through layers of biologic tissue in a patented pattern that it claims creates a unique, embroidered construction. The biological material is derived from ovine rumen, the company said, and is intended to reduce foreign body response, minimize inflammation and enable functional tissue remodeling.

“As a surgeon who has performed thousands of hernia repairs with plastic mesh over the past three decades, I fully understand the clinical limitations of using synthetic mesh to repair human tissue,” Freedman said in a news release. “Unfortunately, plastic mesh h…

Read more
  • 0